Literature DB >> 22189036

ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis.

Alexandre Belot1, Brigitte Bader-Meunier, Patrick Niaudet, Rémi Salomon, Anne-Marie Prieur, Laure-Hélène Noel, Pierre Quartier.   

Abstract

Systemic-onset juvenile idiopathic arthritis is an inflammatory disease of unknown cause and is not commonly associated with kidney involvement. We describe 3 patients with systemic-onset juvenile idiopathic arthritis with high disease activity who developed antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis 1-6 years after the onset of systemic-onset juvenile idiopathic arthritis. Renal and systemic-onset juvenile idiopathic arthritis remission occurred in one patient under anti-interleukin 1 (anti-IL-1) treatment associated with immunosuppressive drugs. The other 2 patients developed end-stage renal disease, and one of those patients died. This report suggests that the diagnosis of ANCA-associated glomerulonephritis must be considered in patients with systemic-onset juvenile idiopathic arthritis with persistently active systemic disease who present with proteinuria. Furthermore, use of an anti-IL-1 agent might be an effective therapeutic option. Copyright Â
© 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189036     DOI: 10.1053/j.ajkd.2011.11.002

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.

Authors:  Eduardo Martín-Nares; Diego Zuñiga-Tamayo; Andrea Hinojosa-Azaola
Journal:  Clin Rheumatol       Date:  2018-07-14       Impact factor: 2.980

Review 2.  Analysis of the clinical characteristics of arthritis with renal disease caused by a NPHS2 gene mutation.

Authors:  Duomei Shi; Yu Zhang; Dawei Liu; Li Xu; Xuemei Tang
Journal:  Clin Rheumatol       Date:  2021-01-11       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.